Substance P

<p>1. The synthesis, release, and binding of substance P<br>Brendan A. Hilliard, Robert Vink, and Mary F. Barbe<br>2. Distribution of substance P receptors in mammals<br>Honoo Satake, Akira Shiraishi, and Tsuyoshi Kawada<br>3. Substance P in nonmammalian biology: Evolutionarily conserved tachykinin signaling<br>Dick R. Nassel<br>4. Methodological foundations of substance P detection<br>Nuray Erin<br>5. Substance P receptor antagonists<br>Francisco D. Rodrıguez and Rafael Covenas<br>6. Substance P in the cardiovascular system<br>Magdalena Chottova Dvorakova and Shashank Pandey<br>7. Substance P in lower urinary tract function and dysfunction<br>Mitsuharu Yoshiyama<br>8. Role of the substance P in learning and memory<br>Natalia Favila and Paul G. Overton<br>9. Substance P in nausea and vomiting<br>Paul L.R. Andrews, John A. Rudd, and Gareth J. Sanger<br>10. Substance P in the central control of respiration<br>Nicholas J. Burgraff and Jan-Marino Ramirez<br>11. Substance P in bone metabolism<br>Tanja Niedermair and Susanne Grassel<br>12. Life without substance P: The naked mole rat<br>Aishi Zhao, Jiwon Lee, Weronika Gryszkiewicz, and Thomas J. Park<br>13. Substance P in inflammation<br>Sophie E. Sipprell and Ian Marriott<br>14. Substance P in oxidative stress<br>Seyed Isaac Hashemy and Safieh Ebrahimi<br>15. Substance P in pain<br>Robert Vink<br>16. Substance P in cancer<br>Miguel Munoz, Marisa Rosso, Riffat Mehboob, and Francisco Esteban<br>17. Substance P in cardiac dysfunction<br>Scott P. Levick and Alexander Widiapradja<br>18. Substance P in neurotrauma<br>Rebecca George, Justin Krieg, and Frances Corrigan<br>19. Substance P in stroke<br>Annabel Sorby-Adams<br>20. Substance P in Alzheimer&rsquo;s and Parkinson&rsquo;s disease<br>Severini Cinzia<br>21. Substance P receptor antagonists for major depressive disorder<br>Nadia M.J. Rupniak and Mark S. Kramer<br>22 From a putative antidepressant to a validated mouse model of ADHD via NK1 receptors<br>S.C. Stanford<br>23. Substance P in stress and anxiety<br>Karl Ebner and Nicolas Singewald<br>24. Substance P-neurokinin 1 receptor pathway in musculoskeletal disorders<br>Brendan A. Hilliard and Mary F. Barbe<br>25. Substance P and sudden infant death syndrome (SIDS)<br>F. Bright, Robert Vink, and R.W. Byard<br>26. Immunobiology and pharmacology of neuropeptide substance P<br>Ehsan Aslam, Asina Gijasi, Caroline Perner, Rob van Wijk, Anne-Grete Martson, Gerard J.P. van Westen, Ilze Bot, Laura H. Heitman, and Alireza Mashaghi<br>27. Substance P in viral diseases—Especially coronavirus disease<br>Riffat Mehboob, Mariam Hashim, and Miguel Munoz<br>28. Substance P: Perspectives and future directions<br>Robert Vink<br> </p>